10/16/2026
💉The US MEF2C Foundation invites you to participate in the Blood Biomarker Investigations in Boston and Chicago. Contact [email protected] to discuss the possibility for other blood draw sites.
📅The investigation entails 3 blood draws spaced approximately 6 months apart. These can be scheduled at your leisure within the scheduled months. The MEF2C diagnosed patient and thier siblings are encouraged to participate.
🔬The purpose of these investigations is to provide the scientific and medical community with a better understanding of MEF2C disease biology and areas of concern. This can uncover disease pathways to inform clinical care and treatments, potentially highlighting commonalities with other rare conditions, suggesting shared therapeutic strategies.
These investigations will measure a broad spectrum of protein pathways focusing on neurology, oncology, inflammation, cardiometabolic and metabolism. It can indicate signs of:
*neurodegeneration / neuroinflammation
*neural development
*synaptic function
*glial cell communication
*blood brain barrier integrity
*immuno-oncology
*cytokine signaling